(833) 317-6278 
The US Food and Drug Administration has approved a messenger RNA-based vaccine against respiratory syncytial virus (RSV) for people aged 60 and older.
Alicia Lasek
Geo Focus
Coverage Attributes:
Beta
Cites Data:
75
%
Government Announcement:
10
%
Press Release:
8
%
Private Sector Announcements:
1
%
Themes Covered:
Not enough data
Pitching Insights
Alicia Lasek's articles primarily focus on healthcare and pharmaceuticals, with a significant emphasis on citing data and government announcements. She would likely be interested in pitches that provide insights from experts or organizations involved in the healthcare sector, especially those related to new research findings, policy changes, or innovative treatments.
Given her extensive use of data in reporting, she may appreciate pitches that include original research or access to unique datasets related to healthcare trends and developments. Sources providing firsthand accounts of successful medical interventions or clinical trials could also capture her interest.
It is important to note that Alicia does not appear to have a specific geographic focus but rather covers national and international topics within the realm of healthcare and scientific advancements.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Health Beat Leader On Aging
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Writer
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
